tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Silvan Tuerkcan, 186 are a BUY (95.88%), 8 are a HOLD (4.12%).
Analyst Silvan Tuerkcan, currently employed at JMP, carries an average stock price target met ratio of 36.36% that have a potential upside of 41.53% achieved within 112 days.
Silvan Tuerkcan’s has documented 378 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRSP, Crispr Therapeutics AG at 23-Dec-2025.
Analyst best performing recommendations are on NUVB (NUVATION BIO).
The best stock recommendation documented was for TERN (TERNS PHARMACEUTICALS) at 10/23/2025. The price target of $15 was fulfilled within 12 days with a profit of $7.5 (100%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Sep-2023
$54
$10.37 (23.77%)
$52
11 days ago
(12-Feb-2026)
9/16 (56.25%)
$11.3 (26.46%)
128
Hold Since 28-Feb-2017
$44
$0.37 (0.85%)
$43
12 days ago
(11-Feb-2026)
16/17 (94.12%)
$1.06 (2.47%)
136
Hold Since 20-Dec-2024
$44
$0.37 (0.85%)
$40
19 days ago
(04-Feb-2026)
5/5 (100%)
$1.35 (3.17%)
204
Hold Since 08-Jan-2026
$49
$5.37 (12.31%)
$48
21 days ago
(02-Feb-2026)
3/6 (50%)
$6.19 (14.46%)
97
Sell Since 05-Jan-2026
$41
$-2.63 (-6.03%)
$46
1 months 18 days ago
(05-Jan-2026)
6/7 (85.71%)
$-1.4 (-3.30%)
63
Which stock is Silvan Tuerkcan is most bullish on?
Which stock is Silvan Tuerkcan is most reserved on?
What Year was the first public recommendation made by Silvan Tuerkcan?
